filmov
tv
FDA Patient Listening Sessions: FDA Staff Reflections: Lewis Fermaglich
Показать описание
Lewis Fermaglich from FDA’s Office of Orphan Products Development describes an impact of the FDA Patient Listening Session program.
U.S. Food and Drug Administration
patients
caregivers
advocates
patient engagement
patient communities
Рекомендации по теме
0:02:58
FDA Patient Listening Sessions: FDA Staff Reflections: Melanie Blank
0:02:23
FDA Patient Listening Sessions: FDA Staff Reflections: Lewis Fermaglich
0:02:55
FDA Patient Listening Sessions: Community Perspectives
0:03:00
What is an FDA Patient Listening Session?
0:03:00
FDA Patient Listening Sessions: Community Perspectives
0:02:02
FDA Patient Listening Sessions: FDA Staff Reflections: Anne Rowzee
0:02:50
FDA Patient Listening Sessions: Community Perspectives
0:01:57
FDA Patient Listening Sessions: Community Perspectives
3:14:27
California State Board of Pharmacy Meeting - January 8, 2025 - 1 of 2
0:02:51
FDA Patient Listening Sessions: FDA Staff Reflections: Erica Lyons
0:02:58
FDA Patient Listening Sessions: FDA Staff Reflections: Julienne Vaillancourt
0:03:11
FDA Patient Listening Sessions: NORD
0:02:29
FDA Patient Listening Sessions: The Reagan-Udall Foundation for the FDA
0:04:32
FDA patient listening session
0:56:13
A Look at Rare Disease Listening Sessions with NORD and the FDA
1:20:13
Stories for Progress: An Update on FSR’s FDA Patient Listening Session 2022
1:34:16
FDA Patient Listening Session 'Drug Development in Molecular Subsets of Non-Small Cell Lung Can...
0:57:12
FDA Listening Session: COVID19 Impact on Rare Disease Communities
0:35:50
PFIC FDA Listening Session
0:09:47
FDA Patient Listening Session on LGMDs
0:32:59
FDA | PWS Patient Listening Session Summary Webinar
0:05:09
Patients Matter: Giving Patients a Seat at the Table
0:09:03
When a Patient Speaks
0:32:59
FDA | PWS Patient Listening Session Summary Webinar